Dr. Andrew Ross Scheinberg, MD

Dr. Scheinberg practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Scheinberg's NPI, 1184086753, was assigned on March 23, 2016. Dr. Scheinberg graduated from University of Miami, Miller School of Medicine in 2016. Dr. Scheinberg holds Florida license ME139308.

Dr. Scheinberg's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Scheinberg's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Scheinberg is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scheinberg practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Scheinberg's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Scheinberg is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Scheinberg is licensed in Florida.

CMS data shows 28 Medicare services from Dr. Scheinberg across 2 procedure codes in 2024, for 61 Medicare patients. Medicare paid $2,661 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Scheinberg in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scheinberg's median patient age at 66, with 52% women.

In 2024, Dr. Scheinberg wrote 171 Medicare Part D claims for 97 patients. 85% of them were for generic drugs. CMS names the drug for 83 of them, across 3 drugs with 11 or more claims each, at $785 in total drug cost. In 2023, CMS named 44 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Scheinberg for performance year 2024, reported as part of a group. Dr. Scheinberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Scheinberg as offering telehealth. CMS counts 52 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Scheinberg, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Scheinberg, published from 2012 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Liver Cirrhosis. Dr. Scheinberg has published most often in Clin Liver Dis. Dr. Scheinberg's most frequent co-authors are Paul David Martin, MD, Paul Martin, MD and Binu John, MD, MPH.

CMS Open Payments shows 7 general payments to Dr. Scheinberg from 3 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $146.

Dr. Scheinberg graduated from University of Miami, Miller School of Medicine in 2016.

Dr. Scheinberg is in network with 8 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.